Brazil Approves First Semaglutide Pen as EMS Challenges Novo Nordisk's Ozempic sheeba farhat27 May 2026 9:53 PM ISTSao Paulo: Brazil's health ​regulator Anvisa said on ​Tuesday it had approved EMS's ​Ozivy, the country's first semaglutide-based injector pen, as the...
EMA Backs Novo Nordisk's Oral Wegovy, Paving Way for Europe's First Weight-Loss Pill sheeba farhat25 May 2026 10:30 AM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Novo Nordisk Nears Europe Launch of Oral Wegovy After EMA Recommendation sheeba farhat23 May 2026 5:02 PM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma Dr. Kamal Kant Kohli6 May 2026 10:00 AM ISTGlucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday...
Novo Nordisk Rebrands Rybelsus as Ozempic Pills to Strengthen US Position sheeba farhat4 May 2026 10:45 PM ISTNew Delhi: Novo Nordisk is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid to capitalize on the brand recognition...
USFDA Says No Clinical Need to Compound GLP-1 Drugs, Novo Nordisk, Eli Lilly Stocks Jump sheeba farhat1 May 2026 10:00 AM ISTNew York: The U.S. Food and Drug Administration (USFDA) on ​Thursday proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key...
AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation sheeba farhat15 April 2026 7:00 PM ISTNew Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
Delhi HC Bars Dr Reddy's from Selling Olymviq Over Similarity with Novo Nordisk's Ozempic Susmita Roy27 March 2026 10:16 PM ISTNew Delhi: The Delhi High Court on Wednesday directed Dr. Reddy's Laboratories to temporarily stop selling its diabetes drug marketed under the brand...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
T2D, Obesity and Heart Failure: Breaking the Pathophysiologic Triangle Dr. Kamal Kant Kohli19 March 2026 10:15 AM ISTIndia's diabetes burden has risen markedly, with 101 million individuals living with diabetes. The clinical burden is compounded by heart failure...
